Does Ketamine Cause Dry Mouth?
Yes, ketamine can cause dry mouth (xerostomia), though it is not one of its most common side effects.
Evidence from FDA Drug Label
The FDA-approved drug label for ketamine does not list dry mouth as a primary adverse effect 1. Instead, the pharmacodynamic profile indicates that ketamine can produce salivation and lacrimation through indirect sympathomimetic activity 1. This suggests that ketamine's typical effect is actually increased salivation rather than dry mouth.
Clinical Research Evidence
However, clinical practice reveals a more nuanced picture:
In chronic pain management: A prospective study of 32 patients receiving long-term ketamine treatment (30 mg orally five times daily for 3 months) found that 19% of patients reported dry mouth during oral therapy 2. This was among the notable side effects, though less common than dizziness (22%) and sedation (19%).
In recreational use: Recent research on recreational ketamine exposure demonstrated significant salivary dysfunction, including alterations in salivary composition with increased amylase and mucin levels, suggesting progressive secretory dysregulation 3. This indicates that chronic ketamine exposure can disrupt salivary gland homeostasis.
Clinical Context
The occurrence of dry mouth with ketamine appears to be:
- Route-dependent: More commonly reported with oral administration than IV use
- Duration-dependent: More likely with chronic/repeated use rather than single-dose anesthetic applications
- Dose-dependent: The 19% incidence was observed at relatively high chronic oral doses (150 mg/day total)
Practical Implications
When using ketamine clinically, particularly for chronic pain management:
- Monitor for xerostomia, especially with oral formulations
- Consider supportive measures (hydration, saliva substitutes) if dry mouth develops
- Be aware this side effect may contribute to treatment discontinuation in some patients (12.5% withdrew due to side effects in the chronic pain study) 2
The paradox exists: While acute ketamine administration typically increases salivation 1, chronic oral use can lead to dry mouth in approximately 1 in 5 patients 2.